ArticlePediatric surgery international2026
Genetic association analysis of lnc-AMFR-1:1 rs4784659 C > T and neuroblastoma susceptibility in Chinese pediatric patients.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundNeuroblastoma, a neuroendocrine tumor of the sympathetic ganglia, is the leading solid extracranial malignancy in children. The lnc-AMFR-1:1 rs4784659 polymorphism in long noncoding RNA (lncRNA) has been reported to be associated with susceptibility to several cancers, but its role in neuroblastoma remains unclear.
methodsWe studied 402 patients with neuroblastoma and 473 cancer-free controls from Jiangsu Province to assess the association between lnc-AMFR-1:1 rs4784659 C > T and neuroblastoma susceptibility using odds ratios (ORs) and 95% confidence intervals (CIs).
resultsAnalysis under any of the genetic models tested failed to reveal a significant link between the rs4784659 C > T polymorphism and neuroblastoma risk (CT vs. CC: adjusted OR = 0.96, 95% CI = 0.73–1.28, P = 0.799; TT vs. CC: adjusted OR = 1.40, 95% CI = 0.77–2.53, P = 0.273; TT/CT vs. CC: adjusted OR = 1.01, 95% CI = 0.77–1.33, P = 0.924; TT vs. CC/CT: adjusted OR = 1.41, 95% CI = 0.79–2.54, P = 0.245). Moreover, stratified analysis revealed no significant associations.
conclusionThis study provided no evidence of an association between the lnc-AMFR-1:1 rs4784659 C > T polymorphism and the risk of neuroblastoma. These findings warrant validation in larger and more diverse populations.
Indexed as
Identifiers
41984207What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.